Broker says these exciting small cap ASX shares have massive upside

Check out these highly rated small cap ASX shares with major upside potential.

| More on:
happy investor, share price rise, increase, up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are on the lookout for options at the small side of the market, then it could be worth considering the two small cap ASX shares named below.

That's because these small caps have been rated as buys with major upside potential by analysts at Bell Potter. Here's what you need to know about them:

AVITA Medical Inc (ASX: AVH)

The first small cap ASX share that Bell Potter is tipping as a buy is Avita Medical.

Avita is the healthcare technology company behind the Recell product. It is a medical device used for the reconstruction of skin in patients with severe (2nd and 3rd degree) burns. Adjacent markets for the product include trauma wounds, vitiligo, and potentially aesthetic use.

Bell Potter was pleased with the company's recent quarterly update. In response, it retained its speculative buy rating with an improved price target of $6.20. This implies potential upside of 83% from current levels.

Commenting on Recell product, the broker said:

Recell is arguably the most important innovation in the treatment of severe burns in several decades. The process uses a small autologous sample of unaffected skin. The proprietary enzyme formulation within the Recell device disaggregates the sample, allowing for the isolation of key cell types responsible for the regrowth of the dermis and epidermis. Once harvested the cells are sprayed onto the wound in a solution.

In respect to potential catalysts, the broker highlights that the "announcement of the label expansion to include soft tissue injury and vitiligo is expected in June with the launch in soft tissue wounds from 1 July." So, stay tuned for that!

Catapult Group International Ltd (ASX: CAT)

Another small cap ASX share to look at is Catapult. It is a global sports technology company that provides elite sporting organisations with real time data and analytics to monitor and measure athletes.

Bell Potter was pleased with Catapult's full-year results release this week. In response, its analysts have put a buy rating on its shares with an improved price target of $1.00. This suggests potential upside of 25% from where they currently trade.

In respect to the result, its analysts commented:

Catapult reported a much better than expected FY23 result with an underlying EBITDA loss of only US$(3.2)m versus our forecast loss of US$(13.1)m. The beat was driven by a better than expected gross margin (75.7% vs BPe 71.5%) and both lower than expected variable (US$26.2m vs BPe US$29.4m) and fixed costs (US$49.8m vs BPe US$54.0m).

The good news is that the broker highlights that the company still has a huge market opportunity to grow into in the future. It said:

Catapult is the clear global leader in wearable athlete tracking solutions and at the end of FY23 had >3,800 elite and professional teams as customers. Despite this leading position, however, only a small fraction of all elite and professional athletes currently have any wearable solution in place so the market is very underpenetrated and there is significant opportunity for growth.

Should you invest $1,000 in Avita Medical right now?

Before you buy Avita Medical shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Avita Medical wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical and Catapult Group International. The Motley Fool Australia has recommended Avita Medical and Catapult Group International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Small Cap Shares

A man slumps crankily over his morning coffee as it pours with rain outside.
Small Cap Shares

Why this Telstra-linked ASX small cap stock just crashed 90%

This small cap is having a very bad session. What's going on?

Read more »

A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
Small Cap Shares

The ASX small-cap stock trading at 'half of the earnings multiple of industry leaders'

A leading fund manager sees a lot of untapped value for this soaring ASX small-cap stock.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Small Cap Shares

These small cap ASX stocks could rise 15% to 70%

Analysts think big returns could be on the cards for buyers of these stocks.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Small Cap Shares

2 under-$5 ASX hidden gems worth your attention

These buy-rated shares are flying under the radar. Let's see why analysts are bullish on them.

Read more »

Miner looking at a tablet.
Resources Shares

2 small-cap ASX mining shares exploding 40%+ on China tariff news

Investors are sending the small-cap ASX mining shares flying higher on Wednesday.

Read more »

Siblings jumping on a trampoline.
Small Cap Shares

3 ASX small-cap shares with a 'solid growth outlook' for 2025

A leading fund manager expects strong growth from these ASX small-cap stocks in 2025.

Read more »

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
Small Cap Shares

Guess which ASX small-cap stock exploded 154% on big US news!

ASX small-cap stocks carry added risk, but also sometimes offer supersized rewards.

Read more »

A group of businesspeople clapping.
Healthcare Shares

This fund returned 109% in 2024. Here are 2 of its best-performing ASX shares

Small caps proved to be the winners last year.

Read more »